摘要 |
FIELD: pharmaceutics.SUBSTANCE: invention refers to pharmaceutical industry and represents composition containing vitamin B9, or folic acid, or folacin and myocardial inositol and alpha-lipoic acid for use in curative treating of polycystic ovary syndrome, sterility and menstrual disorders.EFFECT: invention provides the synergetic effect in treating females with polycystic ovary syndrome, improved spontaneous ovulation activity and considerable increase of frequency of pregnancy.6 cl |